D. Srivastava et al., HEPATIC VENOUS-BLOOD AND THE DEVELOPMENT OF PULMONARY ARTERIOVENOUS-MALFORMATIONS IN CONGENITAL HEART-DISEASE, Circulation, 92(5), 1995, pp. 1217-1222
Background Pulmonary arteriovenous malformations (PAVMs) are a known c
omplication after some types of cavopulmonary anastomoses (CVPAs). The
ir cause is unknown, but they may be related to the absence of pulsati
le flow or the presence or absence of circulating factors. These PAVMs
are diffuse and are presumed to be progressive and irreversible. Meth
ods and Results All patients with congenital heart disease (CHD) seen
at Children's Hospital, Boston, Mass, between 1970 and 1993 were revie
wed. We report on the 10 patients With CHD who were found to have deve
loped PAVMs, as diagnosed by cardiac catheterization. Diagnoses includ
ed heterotaxy syndrome/polysplenia, with interrupted inferior vena cav
a and hepatic veins draining to the right atrium (n=6); heterotaxy/asp
lenia (n=1); corrected transposition with pulmonary stenosis (n=1); an
d biliary atresia and associated CHD (n=2). PAVMs were diagnosed 0.1 t
o 7.0 years (median, 3.5 years) after creation of a CVPA that resulted
in exclusion of hepatic venous flow from one or both lungs in 8 of th
e, 10 patients; the remaining 2 patients had normal drainage of hepati
c veins to the lungs but had biliary atresia. In all, the common anato
mic feature was the exclusion of normal hepatic venous return from the
affected pulmonary arterial circulation. All patients with interrupte
d inferior vena cava, azygous continuation to the superior vena cava,
and hepatic veins draining to the right atrium (polysplenia syndrome)
were reviewed to determine the incidence of PAVMs in those with CVPA (
ie, hepatic Venous flow excluded from the pulmonary arteries) and with
out CVPA. Six of 28 (21%) of those with versus 1 of 56 (1.8%) of those
without CVPA developed PAVMs (P=.004). The 1 patient without CVPA who
had PAVMs also had biliary atresia. Among patients with CVPA, the pro
bability of developing PAVMs was 15% and 28% at 3 and 5 years, respect
ively, after CVPA. The histological and angiographic appearances of PA
VMs after CVPA are similar to those seen in PAVMs associated with hepa
tic cirrhosis. Conclusions We postulate that PAVMs after CVPA are rela
ted to the diversion of normal hepatic venous flow from the pulmonary
circulation. In this sense, these PAVMs may be analogous to those asso
ciated with liver disease, which have been found to resolve after live
r transplantation. Redirection of hepatic flow to the pulmonary bed in
some patients with CHD and PAVMs may lead to reversibility of the PAV
Ms.